To analyse the FBSCreatinine were done by standard methods. FBS, PPBS values were statistically higher in diabetic group than control group. (P< 0.001) and the mean HbA 1C % was also higher in cases (8.73 ±1.52 % & p=0.001). The average serum Zn level in cases was lower than controls (77.98 ± 11.02 vs 115.08 ± 23.91) and p<0.001 with correlation coefficient r =-0.689. Our study revealed a negative relationship between HbA 1C % and serum Zinc in patients with type 2 DM.
Introduction
Diabetes Mellitus is a chronic pan metabolic disorder caused by acquired or an inherited deficiency in insulin or by the ineffectiveness of the insulin secreted.. So deficiency of insulin results in increased level of blood glucose, damage many of the systems, in particular, heart, blood vessels and nerves. It is the major health issue in developing countries like our country. In modern era of public health morbidity and mortality due to infectious disease has fallen markedly. Yet paradoxically, a marked increase in prevalence of Non Communicable Diseases such as, Type 2 DM, CAD, Hypertension, Stroke and Cancer and they become major causes of morbidity and mortality. In2015, 1.6 million deaths were due to Diabetes mellitus and most of all deaths occur before the age of 70 years. According to WHO data the Diabetes will be the 7 th leading cause of mortality in 2030. (1) According to IDF 425 million adults are affected by DM, a total that is set to reach 629 million by 2045. Diabetes is one of the major causes of cardiovascular disease with 1out of 4 Diabetes in patient costs a consequence of cardiovascular complications, Diabetic retinopathy is the major cause of vision loss in working age adults. The occurrence of ESRD is 10 times higher in people with Diabetes. Gestational diabetes mellitus women are at risk of maternal and fetal complications. Losing a limb is one of the most dreadful complications of DM following a diabetic foot ulcer and a major medical problem worldwide. (2) It is studied that, Zinc plays a role in conformational integrity of insulin, as well as synthesis, storage and secretion of insulin. The decreased Zn which affects the ability of the islets of pancreas to synthesis and secrete insulin, lead to insulin resistance particularly in Type 2 DM. (3) Studies by Rai et al.., (4) Tripathy et al .., (5) and Oh and Yoon (6) have reported zinc deficiency in Type 2 DM by demonstrating low zinc in serum. Diabetes affects homeostasis of zinc in various ways, most probably hyperglycemia, rather than primary lesions related to Diabetes which is responsible for the decrease in total body zinc. So blood glucose monitoring is an ideal part of Management. Direct measurement of blood glucose level is limited value, because long term blood glucose control cannot be measured, and is also highly influenced by diet. Pearson's mean blood glucose level over 6-8 weeks of period can be measured by HbA 1C (7) concentration in blood.
It is most reliable indicator of long term hyperglycemia. (8) (10, 11) , Glycated hemoglobin by ion exchange resin method (8, 12, 13) . Blood glucose (FBS, PPBS) by glucose oxidase/ peroxidase method (14, 15) blood urea by Modified Berthelot Method (16, 17) and serum creatinine by Alkaline Picrate Method (18, 19) . Statistical analysis of data was performed by using Microsoft excel software. A p value of less than or equal to 0.001 was considered significant. Correlation was found out in SPSS -21 by using independent sample t test and chi-square test.
Results and Discussion
The present study aims to correlate the serum Zinc status and HbA1C of newly diagnosed Type 2 Diabetes Mellitus patients. For this purpose, 50 diabetic and 50 gender and age matched controls were studied. The comparison of outcome measures is performed by independent sample "t" test. Distribution comparison (ordinal data) is performed by chi-square test of independence. The entire statistical work is worked out by (SPSS-21) Statistical Packages of Social Science.
In my study, out of 50 cases, 36 were males and14 were females and age distribution of the study is shown in table1. It was observed the mean FBS and PPBS in newly diagnosed DM patients were statistically higher than that of the controls. It is observed, that the mean serum Zn level in 50 cases of newly diagnosed DM is 77.98  11.02 and that in 50 controls is 115.08  23.91 and it is highly significant (p<0.001). The mean age of Diabetes was 54.86± 8.31 years. the mean age of control was 51.50±9.45 years. The age distributions is stastistically insignificant (chi-square = 10.20 p= 0.59.) hence the age of two groups is not differed significantly. In the present study, it is observed that the mean HbA 1C concenteration in newly diagnosed type 2 DM patients have negative relationship with serum zinc concentration and vice versa. The Pearson Correlation Coefficient r is found to be -0.689 which also revealed the negative correlations between these parameters. Tripathy et al..,, (5) found a negative correlations among the serum zinc and HbA 1C % with r value of-0.408 in diabetic subjects. The findings of the present study were consistent with Reefat et al..,, (29) who found significant negativecorrelation between serum zinc concentration and baseline HbA 1C % value in the diabetic and found correlation coefficient r to be -0.33. It may be concluded that there is significant reduction of serum Zn in Type 2 Diabetes Mellitus patients. There is an evidence that high blood glucose level interferes with the active transport of zinc back into renal tubular cells leadingto hyperzincuria. Moreover zinc also increases insulin sensitivty at receptor level. (3) . Our data in the study group population of chidambaram, the serum Zn level is decreased and it would be useful, in subsequent studies, to see the effectiveness of any intervention (zinc supplmentation) undertaken in this population.
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